| Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project PM Coloma, MJ Schuemie, G Trifiro, R Gini, R Herings, J Hippisley‐Cox, ... Pharmacoepidemiology and drug safety 20 (1), 1-11, 2011 | 312 | 2011 |
| Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0 SV Wang, S Schneeweiss, ML Berger, J Brown, F de Vries, I Douglas, ... Value in health 20 (8), 1009-1022, 2017 | 207 | 2017 |
| Risk of upper gastrointestinal bleeding from different drug combinations GMC Masclee, VE Valkhoff, PM Coloma, M de Ridder, S Romio, ... Gastroenterology 147 (4), 784-792. e9, 2014 | 203 | 2014 |
| Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions RA Charlton, S Jordan, A Pierini, E Garne, AJ Neville, AV Hansen, R Gini, ... BJOG: An International Journal of Obstetrics & Gynaecology 122 (7), 1010-1020, 2015 | 129 | 2015 |
| Electronic healthcare databases for active drug safety surveillance: is there enough leverage? PM Coloma, G Trifirò, MJ Schuemie, R Gini, R Herings, J Hippisley‐Cox, ... Pharmacoepidemiology and drug safety 21 (6), 611-621, 2012 | 108 | 2012 |
| Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases … R Gini, P Francesconi, G Mazzaglia, I Cricelli, A Pasqua, P Gallina, ... BMC Public Health 13, 1-11, 2013 | 97 | 2013 |
| Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods MJ Schuemie, PM Coloma, H Straatman, RMC Herings, G Trifirò, ... Medical care 50 (10), 890-897, 2012 | 97 | 2012 |
| Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project P Avillach, PM Coloma, R Gini, M Schuemie, F Mougin, JC Dufour, ... Journal of the American Medical Informatics Association 20 (1), 184-192, 2013 | 96 | 2013 |
| The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand? G Trifirò, R Gini, F Barone-Adesi, E Beghi, A Cantarutti, A Capuano, ... Drug Safety 42, 347-363, 2019 | 77 | 2019 |
| Healthcare databases in Europe for studying medicine use and safety during pregnancy RA Charlton, AJ Neville, S Jordan, A Pierini, C Damase‐Michel, ... pharmacoepidemiology and drug safety 23 (6), 586-594, 2014 | 71 | 2014 |
| Useful interplay between spontaneous ADR reports and electronic healthcare records in signal detection AC Pacurariu, SM Straus, G Trifiro, MJ Schuemie, R Gini, R Herings, ... Drug safety 38, 1201-1210, 2015 | 66 | 2015 |
| Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal … VE Valkhoff, PM Coloma, GMC Masclee, R Gini, F Innocenti, F Lapi, ... Journal of clinical epidemiology 67 (8), 921-931, 2014 | 62 | 2014 |
| Prevalence of chronic diseases by immigrant status and disparities in chronic disease management in immigrants: a population-based cohort study, Valore Project A Buja, R Gini, M Visca, G Damiani, B Federico, P Francesconi, D Donato, ... BMC Public Health 13, 1-7, 2013 | 62 | 2013 |
| EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection G Trifirò, V Patadia, MJ Schuemie, PM Coloma, R Gini, R Herings, ... Patient Safety Informatics, 25-30, 2011 | 61 | 2011 |
| Data extraction and management in networks of observational health care databases for scientific research: a comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE strategies R Gini, M Schuemie, J Brown, P Ryan, E Vacchi, M Coppola, W Cazzola, ... Egems 4 (1), 2016 | 59 | 2016 |
| Dementia prevalence and incidence in a federation of European Electronic Health Record databases: the European Medical Informatics Framework resource G Perera, L Pedersen, D Ansel, M Alexander, HM Arrighi, P Avillach, ... Alzheimer's & Dementia 14 (2), 130-139, 2018 | 56 | 2018 |
| How much are biosimilars used in clinical practice? A retrospective Italian population-based study of erythropoiesis-stimulating agents in the years 2009–2013 Y Ingrasciotta, F Giorgianni, J Bolcato, A Chinellato, R Pirolo, DU Tari, ... BioDrugs 29, 275-284, 2015 | 56 | 2015 |
| Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases MJ Schuemie, R Gini, PM Coloma, H Straatman, RMC Herings, ... Drug safety 36, 159-169, 2013 | 55 | 2013 |
| Prevalence of heart failure and adherence to process indicators: which socio-demographic determinants are involved? A Buja, G Solinas, M Visca, B Federico, R Gini, V Baldo, P Francesconi, ... International journal of environmental research and public health 13 (2), 238, 2016 | 54 | 2016 |
| Anticholinergic medication burden and 5-year risk of hospitalization and death in nursing home elderly residents with coronary artery disease DL Vetrano, D La Carpia, G Grande, P Casucci, T Bacelli, R Bernabei, ... Journal of the American Medical Directors Association 17 (11), 1056-1059, 2016 | 53 | 2016 |
Martijn SchuemieJanssen R&DBestätigte E-Mail-Adresse bei ohdsi.org
